149 related articles for article (PubMed ID: 12499895)
1. Remission of hepatitis C virus-associated cryoglobulinemic glomerulonephritis with interferon alfa-2b and ribavirin combination therapy after liver transplantation.
Sikaneta T; Williams WW; Chung RT; Cosimi AB; Pascual AM
Transplantation; 2002 Dec; 74(12):1767-8. PubMed ID: 12499895
[No Abstract] [Full Text] [Related]
2. Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy.
Rossi P; Bertani T; Baio P; Caldara R; Luliri P; Tengattini F; Bellavita P; Mazzucco G; Misiani R
Kidney Int; 2003 Jun; 63(6):2236-41. PubMed ID: 12753313
[TBL] [Abstract][Full Text] [Related]
3. [Hepatitis C virus-related cryoglobulinemic vasculitis with renal involvement: current possibilities of treatment].
Gordovskaia NB; Kozlovskaia LV; Milovanova SIu; Ignatova TM; Korotchaeva IuV
Ter Arkh; 2013; 85(6):78-84. PubMed ID: 23866603
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of HCV-associated cryoglobulinaemic glomerulonephritis with a combination of interferon-alpha and ribavirin.
Misiani R; Bellavita P; Baio P; Caldara R; Ferruzzi S; Rossi P; Tengattini F
Nephrol Dial Transplant; 1999 Jun; 14(6):1558-60. PubMed ID: 10383026
[No Abstract] [Full Text] [Related]
5. Interferon-alpha in combination with ribavirin as initial treatment for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis.
Garini G; Allegri L; Carnevali L; Catellani W; Manganelli P; Buzio C
Am J Kidney Dis; 2001 Dec; 38(6):E35. PubMed ID: 11728995
[TBL] [Abstract][Full Text] [Related]
6. Peginterferon alfa-2b plus ribavirin for the treatment of hepatitis C recurrence following combined liver and kidney transplantation.
Schmitz V; Kiessling A; Bahra M; Puhl G; Kahl A; Berg T; Neuhaus R; Neuhaus P; Neumann U
Ann Transplant; 2007; 12(3):22-7. PubMed ID: 18290566
[TBL] [Abstract][Full Text] [Related]
7. Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study.
Saadoun D; Resche-Rigon M; Thibault V; Piette JC; Cacoub P
Arthritis Rheum; 2006 Nov; 54(11):3696-706. PubMed ID: 17075881
[TBL] [Abstract][Full Text] [Related]
8. Antiviral therapy of symptomatic HCV-mixed cryoglobulinemia after liver transplant: case report and literature review.
Francesca Donato M; Banfi G; Cresseri D; Battista Fogazzi G; Martin P; Messa P; Fabrizi F
Int J Artif Organs; 2013 May; 36(5):367-72. PubMed ID: 23446762
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C in adults and adolescents with hemophilia: a randomized, controlled trial of interferon alfa-2b and ribavirin.
Fried MW; Peter J; Hoots K; Gaglio PJ; Talbut D; Davis PC; Key NS; White GC; Lindblad L; Rickles FR; Abshire TC
Hepatology; 2002 Oct; 36(4 Pt 1):967-72. PubMed ID: 12297845
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of interferon based antiviral therapy for recurrent hepatitis C in patients who received steroid free immunosuppression for liver transplantation.
Nair S; Lipscomb J; Eason J
Transplantation; 2008 Aug; 86(3):418-22. PubMed ID: 18698245
[TBL] [Abstract][Full Text] [Related]
11. Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy.
Neff GW; Montalbano M; O'Brien CB; Nishida S; Safdar K; Bejarano PA; Khaled AS; Ruiz P; Slapak-Green G; Lee M; Nery J; De Medina M; Tzakis A; Schiff ER
Transplantation; 2004 Nov; 78(9):1303-7. PubMed ID: 15548967
[TBL] [Abstract][Full Text] [Related]
12. Duration of antiviral therapy for cholestatic HCV recurrence may need to be indefinite.
Gopal DV; Rosen HR
Liver Transpl; 2003 Apr; 9(4):348-53. PubMed ID: 12682884
[TBL] [Abstract][Full Text] [Related]
13. Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study.
Mazzaro C; Zorat F; Caizzi M; Donada C; Di Gennaro G; Maso LD; Carniello G; Virgolini L; Tirelli U; Pozzato G
J Hepatol; 2005 May; 42(5):632-8. PubMed ID: 15826710
[TBL] [Abstract][Full Text] [Related]
14. Complete remission of cryoglobulinemic glomerulonephritis (HCV-positive) after high dose interferon therapy.
Laganović M; Jelaković B; Kuzmanić D; Sćukanec-Spoljar M; Roncević T; Cuzić S; Ostojić R
Wien Klin Wochenschr; 2000 Jul; 112(13):596-600. PubMed ID: 10944819
[TBL] [Abstract][Full Text] [Related]
15. Interferon alpha 2b and ribavirin for the treatment of recurrent hepatitis C after liver transplantation: cohort study of 38 patients.
Mukherjee S; Lyden E; McCashland TM; Schafer DF
J Gastroenterol Hepatol; 2005 Feb; 20(2):198-203. PubMed ID: 15683421
[TBL] [Abstract][Full Text] [Related]
16. Treatment of transfusion-dependent thalassemic patients infected with hepatitis C virus with interferon alpha-2b and ribavirin.
Sherker AH; Senosier M; Kermack D
Hepatology; 2003 Jan; 37(1):223. PubMed ID: 12500209
[No Abstract] [Full Text] [Related]
17. Combination of interferon-alpha and ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation.
Ben-Ari Z; Mor E; Shaharabani E; Bar-Nathan N; Shapira Z; Tur-Kaspa R
Transplant Proc; 2000 Jun; 32(4):714-6. PubMed ID: 10856556
[No Abstract] [Full Text] [Related]
18. Treatment of hepatitis C-virus-reinfection after liver transplant with silibinin in nonresponders to pegylated interferon-based therapy.
Eurich D; Bahra M; Berg T; Boas-Knoop S; Biermer M; Neuhaus R; Neuhaus P; Neumann U
Exp Clin Transplant; 2011 Feb; 9(1):1-6. PubMed ID: 21605016
[TBL] [Abstract][Full Text] [Related]
19. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.
Bizollon T; Palazzo U; Ducerf C; Chevallier M; Elliott M; Baulieux J; Pouyet M; Trepo C
Hepatology; 1997 Aug; 26(2):500-4. PubMed ID: 9252166
[TBL] [Abstract][Full Text] [Related]
20. Renal manifestations of hepatitis C virus infection. Extrahepatic complications often are silent--and thus overlooked.
Bandi L
Postgrad Med; 2003 Feb; 113(2):73-6, 86. PubMed ID: 12611116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]